We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
66 hedge funds and large institutions have $17.2M invested in Accelerate Diagnostics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
4% less capital invested
Capital invested by funds: $18M → $17.2M (-$755K)
8% less funds holding
Funds holding: 72 → 66 (-6)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
72% less call options, than puts
Call options by funds: $8K | Put options by funds: $29K
Holders
66
Holders Change
-6
Holders Change %
-8.33%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
11
Reduced
13
Closed
16
Calls
$8K
Puts
$29K
Net Calls
-$21K
Net Calls Change
+$75K
Top Buyers
| 1 |
GAM
Griffin Asset Management
New York
|
+$1.01M |
| 2 |
AF
Allworth Financial
Folsom,
California
|
+$92.6K |
| 3 |
TC
Tejara Capital
London,
United Kingdom
|
+$60.1K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$35.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$30.1K |
